StockNews.AI
NOVT
StockNews.AI
203 days

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 25, 2025

1. Novanta schedules Q4 and full-year 2024 earnings release for February 25, 2025. 2. A conference call will follow, emphasizing financial transparency. 3. Events will be accessible via phone or online webcast. 4. Previous fiscal performance could impact investor sentiment. 5. The company continues focusing on precision technology solutions.

6m saved
Insight
Article

FAQ

Why Neutral?

Upcoming earnings release is standard; can influence short-term stock movement. Previous releases have shown mixed reactions.

How important is it?

Earnings releases are pivotal, influencing stock prices considerably. However, specifics matter greatly.

Why Short Term?

Immediate effects expected around the earnings release date. Previous patterns reveal stock fluctuation post-earnings.

Related Companies

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 25, 2025

BEDFORD, Mass.--( )--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and full year 2024 results on Tuesday, February 25, 2025.

The Company will host a conference call on Tuesday, February 25, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company’s website at www.novanta.com.

A replay of the audio webcast will be available approximately three hours after the conclusion of the call on the Events & Presentations page of the Investors section of the Company’s website at www.novanta.com. The replay will remain available until Monday, April 21, 2025.

About Novanta

Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technical challenges. This enables Novanta to engineer proprietary technology solutions that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation, the Novanta Growth System, and our customers’ success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol “NOVT.”

More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.

Contacts

Novanta Inc.
Investor Relations Contact:
Ray Nash
(781) 266-5137

Related News